Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
This study has been completed.
Study NCT00490542   Information provided by Tufts Medical Center

First Received on June 20, 2007.   Last Updated on November 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Bipolar Depression
Depression
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
ziprasidone (Geodon)
placebo
Additional drug interventions recognized in this trial
Ziprasidone
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Tufts Medical Center
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services